Correlation Engine 2.0
Clear Search sequence regions


  • antitumor (1)
  • diagnosis (1)
  • female (4)
  • humans (1)
  • normal (1)
  • peptides (13)
  • prognosis (1)
  • women health (1)
  • Sizes of these terms reflect their relevance to your search.

    Antimicrobial peptides (AMPs) are essential components of the mucosal barrier of the female reproductive tract (FRT) and are involved in many important physiological processes, including shaping the microbiota and maintaining normal reproduction and pregnancy. Gynecological cancers seriously threaten women's health and bring a heavy burden to society so that new strategies are needed to deal with these diseases. Recent studies have suggested that AMPs also have a complex yet intriguing relationship with gynecological cancers. The expression level of AMPs changes during tumor progression and they may act as promising biomarkers in cancer detection and prognosis prediction. Although AMPs have long been considered as host protective, they actually play a "double-edged sword" role in gynecological cancers, either tumorigenic or antitumor, depending on factors such as AMP and cancer types, as well as AMP concentrations. Moreover, AMPs are associated with chemoresistance and regulation of AMPs' expression may alter sensitivity of cancer cells to chemotherapy. However, more work is needed, especially on the identification of molecular mechanisms of AMPs in the FRT, as well as the clinical application of these AMPs in detection, diagnosis and treatment of gynecological malignancies.

    Citation

    Chongyi Zhao, Shuo Yan, Yuzhu Song, Xueshan Xia. Roles of Antimicrobial Peptides in Gynecological Cancers. International journal of molecular sciences. 2022 Sep 03;23(17)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36077500

    View Full Text